{"protocolSection":{"identificationModule":{"nctId":"NCT04524416","orgStudyIdInfo":{"id":"STAR-GLOBAL (ISM09)"},"organization":{"fullName":"iSTAR Medical","class":"INDUSTRY"},"briefTitle":"MINIject Global Long-Term Follow-up Study","officialTitle":"A Prospective, Open, Multicentre Study Analysing the Long-term Safety of MINIject Glaucoma Implants in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications","acronym":"STAR-GLOBAL"},"statusModule":{"statusVerifiedDate":"2025-02","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2020-08-05","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-12","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-12","type":"ESTIMATED"},"studyFirstSubmitDate":"2020-08-20","studyFirstSubmitQcDate":"2020-08-20","studyFirstPostDateStruct":{"date":"2020-08-24","type":"ACTUAL"},"lastUpdateSubmitDate":"2025-02-26","lastUpdatePostDateStruct":{"date":"2025-02-28","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"iSTAR Medical","class":"INDUSTRY"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The study will assess the long-term (up to 5 years) safety and performance in patients with open-angle glaucoma uncontrolled by topical hypotensive medications who had previously been implanted with a MINIject glaucoma implant.","detailedDescription":"The study aims to assess long-term safety and performance of MINIject glaucoma implant up to 5 years post-implantation. Patients who received implant and were followed for 2 years in a previous study, will be invited to continue long-term follow-up from 2 to 5 years post-implantation at annual intervals. Standard ophthalmologic assessments including measurement of intraocular pressure, fundus examination, ocular imaging, assessment of any untoward ocular events etc. will be performed."},"conditionsModule":{"conditions":["Open Angle Glaucoma","Ocular Hypertension"],"keywords":["Open Angle Glaucoma","Intra Ocular Pressure (IOP) reduction","Glaucoma Drainage Device","Minimally Invasive Glaucoma Surgery (MIGS)","Supraciliary space","Ocular hypertension"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"OTHER","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":300,"type":"ESTIMATED"}},"armsInterventionsModule":{"interventions":[{"type":"DEVICE","name":"Minimally invasive glaucoma surgery (MIGS)","description":"MINIject implant placed into supraciliary space. The implantation was done in a previous study in which patient participated and is not part of this study."}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Proportion of patients with serious device-related adverse event in study eye","description":"The proportion of patients with at least one serious ocular adverse event in the study eye, related to the device, occurring between 2 and 5 years after the MINIject implantation.","timeFrame":"5 years post-implantation"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient who received a MINIject glaucoma implant within a prior clinical study\n* Patient continues to have MINIject implanted at the point of enrolment\n* Patient must provide written informed consent to participate\n\nExclusion Criteria:\n\n* Individuals under tutorship or trusteeship\n* Patient who is unwilling to return to the study visits and undergo study assessments, as required by clinical study protocol","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"99 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"patients with open-angle glaucoma not-controlled with hypotensive medications and who, to treat this condition, already received MINIject in a previous study","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Esma Islamaj, PhD","role":"CONTACT","phone":"+32 10 77 12 52","email":"esma.islamaj@istarmed.com"},{"name":"Pascale Ducloux","role":"CONTACT","email":"pascale.ducloux@istarmed.com"}],"overallOfficials":[{"name":"Zubair Hussain, PhD","affiliation":"iSTAR Medical","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Clinica Oftalmologica del Caribe","status":"RECRUITING","city":"Barranquilla","country":"Colombia","contacts":[{"name":"Jose Luis Rodriguez, MD","role":"CONTACT"},{"name":"Jose Luis Rodriguez, MD","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Andrea Vasquez, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":10.96854,"lon":-74.78132}},{"facility":"Center Hospotalier Universitaire Genoble Alpes","status":"ACTIVE_NOT_RECRUITING","city":"Grenoble","zip":"38043","country":"France","geoPoint":{"lat":45.16667,"lon":5.71667}},{"facility":"Hopital de la Croix-Rousse","status":"ACTIVE_NOT_RECRUITING","city":"Lyon","zip":"69417","country":"France","geoPoint":{"lat":45.74848,"lon":4.84669}},{"facility":"Uniklinik Köln","status":"ACTIVE_NOT_RECRUITING","city":"Köln","state":"Nordrhein-Westfalen","zip":"50937","country":"Germany","geoPoint":{"lat":50.93333,"lon":6.95}},{"facility":"Universitätsklinikum Mainz","status":"ACTIVE_NOT_RECRUITING","city":"Mainz","state":"Rheinland Pfalz","zip":"55131","country":"Germany","geoPoint":{"lat":49.98419,"lon":8.2791}},{"facility":"Klinikum der Universität München","status":"RECRUITING","city":"München","zip":"81377","country":"Germany","contacts":[{"name":"Marc Mackert, MD.","role":"CONTACT"}],"geoPoint":{"lat":48.13743,"lon":11.57549}},{"facility":"Maxivision Eye Hospital","status":"RECRUITING","city":"Hyderabad","state":"Telangana","zip":"500034","country":"India","contacts":[{"name":"Anitha Kamarthy, MD","role":"CONTACT"},{"name":"Kasu Prasad Reddy, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":17.38405,"lon":78.45636}},{"facility":"Panama Eye Center","status":"ACTIVE_NOT_RECRUITING","city":"Panama City","country":"Panama","geoPoint":{"lat":8.9936,"lon":-79.51973}},{"facility":"Hospital Clínico San Carlos","status":"ACTIVE_NOT_RECRUITING","city":"Madrid","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2025-07-07"},"conditionBrowseModule":{"meshes":[{"id":"D005901","term":"Glaucoma"},{"id":"D005902","term":"Glaucoma, Open-Angle"},{"id":"D009798","term":"Ocular Hypertension"},{"id":"D006973","term":"Hypertension"}],"ancestors":[{"id":"D014652","term":"Vascular Diseases"},{"id":"D002318","term":"Cardiovascular Diseases"},{"id":"D005128","term":"Eye Diseases"}],"browseLeaves":[{"id":"M10024","name":"Hypertension","asFound":"Hypertension","relevance":"HIGH"},{"id":"M9013","name":"Glaucoma","asFound":"Glaucoma","relevance":"HIGH"},{"id":"M9014","name":"Glaucoma, Open-Angle","asFound":"Open Angle Glaucoma","relevance":"HIGH"},{"id":"M12731","name":"Ocular Hypertension","asFound":"Ocular Hypertension","relevance":"HIGH"},{"id":"M17400","name":"Vascular Diseases","relevance":"LOW"},{"id":"M8271","name":"Eye Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC11","name":"Eye Diseases"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M4277","name":"Antihypertensive Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"AnAg","name":"Antihypertensive Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}